Search results
How improving eConsent can enhance patient retention for clinical trials
Clinical Trials Arena via Yahoo Finance· 3 days agoLow patient retention rates are an ongoing pain point for clinical trials, causing costly delays and...
Opinion | Choosing a Primary Care Specialty Should Be Lauded, Not Discouraged
MedPage Today· 3 days agoVisits are often crammed into 10-15 minutes, during which patients and physicians can only begin to...
iTeos Therapeutics and GSK begin Phase III trial of combination therapy for NSCLC
Clinical Trials Arena via Yahoo Finance· 5 days agoBased in Massachusetts, iTeos currently has three clinical-stage programmes targeting novel and...
The 10 Best Performing Stocks So Far In 2024
Forbes· 2 days agoThe stocks have been on a tear with year-to-date gains ranging from 387% to more than a jaw-dropping 1,100% (as of June 14’s market close). The stock market has been buoyant in 2024, debunking ...
Should You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
Zacks· 4 days agoFree Report) , a clinical-stage company, is focused on developing novel therapeutics to treat chronic, high-prevalence retinal diseases, which are the major causes of blindness ...
Cancer risks are far higher for LGBTQ folks. Here's how health justice groups are fighting back
Salon via Yahoo News· 5 days agoAnd despite persistent backlash from far-right groups over LBGTQ activism, clinical studies show...
A simple blood test may soon allow diagnoses of early-stage Parkinson’s disease
Courthouse News Service· 5 days agoThe study authors say that a blood test for a specific panel of proteins can be used to predict the...
A study identified 6 types of depression. Here’s why that matters
CNN via Yahoo News· 3 days agoAnother issue is that the study investigated only one form of psychotherapy and three medications;...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
North Dakota Monitor via Yahoo News· 8 hours agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
Fate Therapeutics stock upgraded by Piper Sandler on autoimmune focus By Investing.com
Investing.com· 6 days agoThe biopharmaceutical company, known for its work in developing programmed cell therapies for cancer...